Share this

STELLAR Study

Reference:

  1. Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16):1478-1490.

In STELLAR, a 24-week study of adult patients with PAH on stable background therapy1:

Reference:

  1. Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulrnonary arterial hypertension. N Engl J Med. 2023;388(16):1478-1490.
  2. Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16) (suppl):S1-S69.


In STELLAR, a 24-week study of adult patients with PAH on stable background therapy1:

Reference:

  1. Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulrnonary arterial hypertension. N Engl J Med. 2023;388(16):1478-1490.
  2. Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16) (suppl):S1-S69.

In STELLAR, a 24-week study of adult patients with PAH on stable background therapy1:

Reference:

  1. Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulrnonary arterial hypertension. N Engl J Med. 2023;388(16):1478-1490.
  2. Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16) (suppl):51-569.

In STELLAR, a 24-week study of adult patients with PAH on stable background therapy1:

Reference:

  1. Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulrnonary arterial hypertension. N Engl J Med. 2023;388(16):1478-1490.
  2. Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16) (suppl):51-569.

In STELLAR, a 24-week study of adult patients with PAH on stable background therapy1:

Reference:

  1. Hoeper MM, Badesch DB, Ghofrani HA, et al; STELLAR Trial Investigators. Phase 3 trial of sotatercept for treatment of pulrnonary arterial hypertension. N Engl J Med. 2023;388(16):1478-1490.
  2. UAE Winrevair SPC

In STELLAR, a 24-week study of adult patients with PAH on stable background therapy1:

Reference:

  1. Hoeper MM, Badesch DB, Ghofrani HA, et al. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16):1478-1490.

In STELLAR, a 24-week study of adult patients with PAH on stable background therapy1:

Reference:

  1. Hoeper MM, Badesch DB, Ghofrani HA, et al. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16):1478-1490.

AE-SOT-00097 Expiry date: 24-5-2028